Phenolic compounds in red wine may protect low-density lipoprotein,s (LDL) against oxidative modification, thereby reducing the risk of cardiovascular morbidity. However, in vivo data are scarce. We gave 13 healthy volunteers 550 mL red wine and another 11 volunteers white wine for 4 wk in a random ized double-blind trial. Interference by alcoholic components of wine was eliminated by reducing the alcohol content to 3.5%. Red wine did not affect the susceptibility of LDL to C ir 1 -mediated oxidative modification [lag time before and after red wine drink ing: Cv ± SO) 61.8 ± 7.7 und 62.7 ± 11,8 min, respectively; lag time before and after white wine drinking: 64,5 ± 10.4 and 63.3 ± 10.8 min, respectively]. Concentrations of the antioxidants urate, vitamin C, and glutathione in plasma and of vitamin E and ubiquinol-10 in LDL were also unchanged after either red or white wine consumption. The results of this study do not show a beneficial effect of red wine consumption on LDL oxidation.
INTRODUCTION
Populations with a high intake of cholesterol and saturated fat have a high mortality from coronary heart disease (CHD) (1) . France is an exception, the CH D mortality is low despite a diet high in saturated fat (2, 3) . The high consumption of alcohol-containing beverages, such as red wine, may, at least in part, explain this so-called French paradox. Alcohol consump tion increases plasma concentrations of high-density-lipopmtein (1IDL) cholesterol (4, 5) . Moderate red wine consumption was also found to be associated with a favorable change in hemostatic factors, such as blood platelet aggregation (3) . The question is whether the supposed cardioprotective effect of red wine can be explained solely by the alcohol component.
In the Zutphen Elderly Study and the Seven Countries Study, the risk of mortality from CHD was negatively correlated with intake of certain flavonoids (6, 7) . Flavonoids consist of two phcnylbenzenc (chromanol) rings linked through a pyran ring. They are present in fruit, vegetables, and beverages such as tea and wine. The most important water-soluble polyphenols with antioxidative capacities in red wine are the flavonols querce tin and myricetin, and the 3-flavanols catechin and epi(gailo)cateehin. 'These are derived from the skin of the grape and are therefore not present in white wine, Flavonoids are mainly responsible for the «stringency, flavor» and color of red wine.
Frankel el al (8) reported that flavonoids extracted from Californian red wine protected low-density lipoprotein (LDL) against oxidation when added in vitro. The oxidative modifi cation of L D L is thought to play a key role in the development of early atherosclerotic lesions (9) . Red wine flavonoids could inhibit L D L oxidation (8, (10) (11) (12) (13) .
Data in vivo are contradictory. Fuhrman et al (14) found that L D L oxidation was inhibited in subjects who had drank red wine, whereas Sharpe et al (15) did not find such an effect. We focused on the effect of the nonalcoholic components of red wine by reducing the alcohol content. Thus, we assessed whether the consumption of low-alcohol red wine affects the oxidizability of L D L and the concentrations of antioxidants in
SUBJECTS AND M ETHODS

Study design
This study was approved by the ethical committee of the Academic Hospital, University of Nijmegen, and atl subjects gave their informed consent before participation. Twenty-four healthy nonsmoking, normolipidemic volunteers (aged 22-63 y; 19 males, 5 females) participated. Subjects were noi using vitamin or mineral supplements, Before study entry subjects* average total alcohol consumption was 0-240 g aleohol/wk. Eleven subjects were moderate red wine drinkers (2¿l..120 g aleohol/wk), All subjects consumed white wine lor a 2-wk baseline period ( Figure I ). They were then randomly assigned to consume white or red wine for another 4 wk (tesi period), with stratification for age, sex, and plasma cholesterol concen tration. F IG U R E 1, Study design, All subjects consumed low-nlcoliol white wine ibi* 2 wk before being randomly assigned to consume low-alcoliol red or white wine lor im additional 4 wk, the red wine and the white wine groups was .seven and four, respectively. Ten men and three women aged 38.2 ± 9,8 y I with a plasma total cholesterol concentration of 5.25 it 0,71 mmol/L and a body mass index (in kg/nr) of 22,8 ± 2.2] received red wine and nine men and two women aged 36.4 ± 11.8 y (with a plasma total cholesterol concentration of 5.37 ± 0,82 mmol/L and a body mass index, of 22.7 ± 2.1) continued to consume white wine.
Participants consumed 550 mL wine (lour to five glasses, ^1 2 g alcohol/d per person) in the evening, Wine was deliv ered daily to the volunteers. All subjects followed a lowflavonoid diet and abstained from tea and,red wine. Food intake was checked by 5-d written records. Intake of quercetin, kaempferol, myrieetin, api gen in, and luteo lift was estimated by using data from Hertog et al (16) .
Preparation of wines
We used white wine from the Loire region in France (Baron Charles, 1993) and red wine from Italy (Chianti Classico, 1991) because this red wine tends to have higher querce tin contents than French wines (17) . Alcohol was removed by evaporation at 35 nC under a pressure of 2 cm Mg. Total volume loss was < 15%. Final alcohol concentrations (,v ± SEM) were 3.5 ± 0.2% for white wine and 3.4 ± 0.3% for red wine. The alcohol content was determined by using a Bochringer Mannheim test kit (no. 176290; Mannheim, Ger many). Nonpolyphenolic pigments (H I02, 4-(4'-su!fo-l'-phi> ny 1 azo)-1 -( 4 \su 11 o p h e ny 1 V 5 -h y d r o x y py r a/.o 1 o n -3 -e a r bo n i e acid; EIK), chinophtalon-disulfate; E122 2-(4'-sulfo-r-naph-tylazo>l-naphlol-4"Sulíate; E l 32, indÍgotm-5'-disulfatc; and El 51, Brilliant Black; Jacob Hooi, Linimen, Netherlands) and red beet (root) juice (37.5 niL/L; Loverendale, Netherlands) were added to both wines to make them indistinguishable. In addition, the wines were coded with random codes. As a result, subjects were unable to distinguish white from red wine. Quer cetin and myrieetin concentrations were determined essentially as described by Hertog et al (16) . Catechin, epieatechin, and epigalloeateehin were determined essentially as described by Bailey and Nursten (18) . Before removal of the alcohol the red wine contained (wet wt) 6.2 ± 0.2 mg quere et in/kg, 3.4 ± 0.2 mg myricetin/kg, 27 mg catechin/kg, 20 mg epieateehin/kg, a nd I I 6 m g ep i gal l oc atech i n/kg. The w h i le wine eon ta i ned < 0 .1 mg quercctin/kg, 1 * I mg myricetin/kg, and 2 mg gallate/ kg. The low-alcohol red wine contained 6.1 ± 0.1 mg quercetin/kg, 3.3 ± 0,1 mg myricetin/kg, 12 mg eateehin/kg, 19 mg epicatechin/kg, and 107 mg epigalloeateehin/kg. The low-al cohol white wine contained < 0.1 mg quercetin/kg, I mg myricetin/kg, and 2 mg gallate/kg.
In vitro measurement of antioxidant capacity of wine
To determine the antioxidant activity of the two wines in vitro, plasma (containing 1 mmol EDTA/L) from a normolipidemic donor was dialyzed against two changes of I L chelex 100-treated phosphate-buffered saline at 4°C to remove con taminating transition metal ions (19) . Before the incubation, 1 mL plasma was preincubated with 10-50 ju-L white or red wine for 5 min at 37 °C, followed by addition of 94 mmol/L 2,2'azobis( 2-ami dì nopropane) hydrochloride (AAPH) (200 /¿L 625 mtnol AAPH/L in 0.154 mol NaCI/L) (Polyselenees, Ine, Warrington, FL). AAPH generates water-soluble peroxy radi cals at a constant rate (19) . After 3 h of incubation, the oxidation was stopped by refrigeration and the degree of li pici peroxidation was assessed by measuring the amount of thiobarbituric acid-reactive substances (TBARS), expressed as /xmol malondialdehyde (MDA) cquivalents/L plasma (20, a modification of 21).
Blood measurements
Two fasting blood samples were collected 10-12 h after wine consumption into evacuated lubes on separate days at the end of both the baseline and test periods. Blood was collected into tubes containing K3-EDTA (1 g/L) for cholesterol, cxtocopherol, ubiquinol-10, and glutathione determinations and for the oxidation assay. Additive-free tubes were used for urate and lithium-heparin-containing tubes for vitamin C. Blood was placed immediately on ice and plasma was separated by cen trifugation at 3200 X # for 8 min at 4 °C within 1 h of sampling. Plasma aliquots were rapidly fro zed in nitrogen and stored at -80 °C after the addition of saccharose (6 g/L) to stabilize the lipoproteins. Butyl ated hydroxy toluene (linai, con centration 250 mg/L), a lipophilic antioxidant, was added to the plasma samples used for the measurement of a-tocopherol and ubiquinol-10 concentrations and TBARS.
Cholesterol concentrations were determined with an enzy matic method with reagent from Bochringer (CHOD-PAP re no. 1442350; Bochringer Mannheim Mannheim, Germany) on a Hitachi 747 analyzer (Bochringer Mannheim), H DL cholesterol was quantified in plasma after precipitation of LDL and very "low-density lipoprotein/i ntcrmediate-density li poprotein with the polyethylene glycol 6000 method (22) . For the ox i dati on assay, the protein content of LDL was measured by the method of Lowry et ai (23) , with chloroform extraction to remove turbidity, and using bovine serum albumin as a standard. The interassay CVs were < 2% for both cholesterol and triaeylglycerol determinations.
Samples of the same subjects were always analyzed in the same run. In each run, samples obtained from subjects who received red wine were analyzed together with samples ob tained from subjects who received white wine. Ascorbic acid and ubiquinoMO were analyzed within 30 min after thawing.
Determination of antioxidant concentrations
Glutathione was determined in whole blood by an enzymatic method according to Griffith (24) . The oxidized form of glu tathione (GSSG) was determined within 6 h of blood sampling.
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The reduced form of glutathione (GSH) was determined within 4 wk in the acid, protein-free suponíate. Urate in serum was determined within 3 h with a Hitachi 747 analyzer (25) , Vita min C (sum of i .-ascorbic and dchydro-L-ascorbie acid) in whole blood was determined by HPLC with fluoromctric detection (26) . «-Tocopherol and ubiquinoMO were determined within 2 wk of storage by HPLC coupled to an electrochemical detector (Decade; Antee, Leiden, Netherlands) (27) . To determine an tioxidant concentrations in LDL, L D L was isolated by a shortrun nonequilibrium density-gradient ultracentrifugation (120 000 X for 4 h at 4 °C) using a Kontron T IT 45.6 fixed-angle rotor (Kontron AG» Zurich, Switzerland) (28) . A f ter isolation, LDL preparations were immediately assayed for antioxidants as described above. To prevent oxidation of ubiquinol-10, LDL was not dialyzed. The concentration was expressed per mmol LDL cholesterol because of potential contamination with trace amounts of albumin.
Oxidizability of LDLs
Oxidation experiments were performed within 2 mo of stor age. Plasma samples of participants were thawed rapidly and LDL was isolated by density ultracentrifugation (285 000 X g for 18 h at 4 °C) using a swingout Beckman SW40 rotor in a Beckman L55 ultracentrifuge (Beckman, Palo Alto, CA). To protect the LDL against oxidative modification during isola tion, 10 /xmol EDTA/L was added to each density solution. LD L was isolated at a density of LO 19-1.063 kg/L, L D L was not dialyzed. The time between isolation and the oxidation experiment was always < 90 min. The susceptibility of LD L to in vitro C i r 1 -mediated oxidation was determined as described by Esterbauer et al (29) as modified by Prineen et al (30) , After isolation, LDL was diluted immediately with NaChEDTA (1.18 mol/L: 10 /xmol/L) to a final concentration of 114 mg protein/L, and sodium phosphate (pH 7.4) was added to a final concentration of 10 mmol/L,. Oxidation was initiated by adding CuSO;, to a final concentration of 38 /umol/L at 37 °C. The kinetics of the oxidation of LDL were determined by monitor ing the change of the 234-nm diene absorption in a thermostatcontrolled ultraviolet spectrophotometer (Lambda 12; Perkin Elmer, Gouda, Netherlands), equipped with a nine-position automatic sample changer. Absorbance curves of four LDL preparations from one subject, two before and two after the test period, were analyzed in parallel. In this way small differences in the oxidation parameters between the LDL preparations isolated from the plasma before and after the test period could be detected. Each LDL preparation was oxidized in two oxi dation runs on the same day. The oxidation assay was validated by analyzing one reference LDL, prepared from pooled plasma stored at ~~80 °C, in every oxidation run. Por the reference LDL, the inlerassay CV for lag time, oxidation rate, and the total amount of conjugated dtenes formed per milligram of LDL protein were < 3%.
Statistical methods
For each subject the change of each variable was calculated as the mean of the two values obtained at the end of the lest period minus the mean at the end of the baseline period. 'The null hypothesis was that the mean of the changes in the red wine group equalled those in the while wine group. This hypothesis was tested by a i test. Repeated-measures analysis of variance (ANOVA) was used to assess the effect of the baseline versus the test period and of white versus red wine.
Where F test results were significant, the results of unequal variances with separate degrees of freedom were used, Where F test results were not significant, results from the pooled degrees of freedom were used. All data analyses were per formed by using SPSS/PC software (SPSS Inc, Chicago),
RESULTS
The daily average intake of the sum of quercetin, kaempferol, myrieetin, api gen in, and luteolin from food was 8.1 ± 4,6 mg in the white wine group and 10.0 ± 6,0 mg in the red wine group, The daily additional intake of quercetin plus myrieetin was 5.3 mg from red wine and 0.6 mg Irom white wine. Beside these two davonoids, high concentrations of catechin-like flavonoids are present, in red wine; but in this study the additional dietary intake of the latter could not be calculated.
Wine inhibited AAPH-indueed lipid peroxidation when added in vitro to plasma (Figure 2 ). At 5%, native red Chianti wine inhibited lipid peroxidation by 61 %, as measured with the TBARS assay, whereas no effect was found with white wine even when it was added at a final concentration of 10%. The low-alcohol red wine plus colorants as given to the participants exerted the same protective effect on plasma oxidation in vitro as did the native red wine. Likewise, the low-alcohol white wine plus added colorants failed to inhibit the AAPH-indueed lipid peroxidation when added to plasma in vitro ( Figure 2 ) .
In contrast with the in vitro findings, consumption of either wine for 4 wk did not affect L D L oxidizability, measured either as lag times, oxidation rate» or final amount of diene formation. Lag times, reflecting the resistance of isolated LDL against oxidative modification, were similar in both wine groups and were not prolonged after consumption of 550 mL red wine/d for 4 wk ( Table 1) ' x ± SD.
.v; 95% CI in parentheses.
protected against oxidation. In three subjects with a basal flavonoid intake > 15 mg, lag times after red wine consump tion were also not different from baseline values. The rate of diene formation and the maximal amount of di enes formed after red wine consumption were not different from baseline values (Table I) . Antioxidant concentrations were not affected either; the mean value for «-tocopherol was 4.J ± LI /xmol/ mmol LD L cholesterol at baseline and 4,1 ± 1.1 after red wine drinking, and the content of ubiquinol-10 was 86 ± 51 nmol/ mmol LDL cholesterol and changed to 91 ± 69 (NS). The concentrations of aqueous and lipophilic antioxidants in plasma were also unchanged ( Table 2 ) as were TBARS (baseline and test values: 1.08 ± 0.27 and 0.99 ± 0.13 jumol/L, respective ly). Total cholesterol, L D L cholesterol, HDL cholesterol, and total triacylglycerol concentrations in plasma did not change significantly in either group (Table 3) ,
DISCUSSION
In our double-blind study consumption of four to five glasses of red wine per day for 4 wk did not affect copper-mediated LDL oxidation in healthy volunteers, «-Tocopherol and ubiquinoMO concentrations of LDL after red wine consump tion were similar to baseline values.
Interest in red wine flavonoids has been stimulated by the growing evidence that free radical-mediated events are in volved in the early formation of fatty streaks in coronary arteries (9) . The beneficial effect of red wine consumption on the prevention of CHD (31) might be due to the HDL-raising effect of ethanol rather than of flavonoids, We therefore used wine from which most of the alcohol had been removed. This was evidently successful because no effect on plasma HDLcholesterol concentrations was seen. The lack of change in plasma lipids also prevented compositional changes in LDL, which can influence LDL oxidizability (32, 33) .
Our data conflict with those of Fuhrman et a! (14) , who observed a fourfold increase in the lag phase before oxidation of LDL in volunteers who had consumed 500 mL red wine compared with white wine. The effect was seen after 2 wk of treatment, but no difference was seen after I wk. The extent of the effect that Fuhrman et al saw is surprising: high doses of vitamin E (30, (34) (35) (36) decreased LDL oxidizability only 1.3-to TABUS 2 Coneentnitions of anlioxidants in plasma or blood at the end of die 2-wk baseline period (while wine) and after the 4-wk test period (red or while wine) Red wine' (n * 13) «-Tocopherol (/¿mol/L plasma) Baseline 2.5-fold, ancl even long-term treatment with the most efficient antioxidant known, probueol (250 mg/d for 4 mo), prolonged the lag time by no more than threefold (37) . The fourfold increase in lag time reported by Fuhrman et al (14) for a relatively modest intervention is thus unprecedented and diffi cult to explain. The design of our study differed from that of Fuhrman el al (14) by having a baseline period of 2 wk with white wine, followed by a 4-wk treatment. The effect of red wine consump tion on LDL, oxidizability was expected to be greater after 4 than after 2 wk. In contrast with the study of Fuhrman et al, all subjects followed a low-flavonoid diet during the study. There were also essential differences in the methods used by both research groups for measuring LDL oxidizability, ie, the omis sion of the dialysis step in our procedure to prevent early oxidative modification of LDL. The red Italian wine we used showed the same antioxidative capacity in vitro as that found by Fuhrman et al (14) with French wine. This antioxidative capacity was not influenced by reduction of the alcohol content or addition of pigments and beet juice used for blinding. Flavonoid concentrations of the red wine were similar to those measured in French wines (38, 39) , and were not changed by these manipulations. In addition, flavonoid concent rati (ins in plasma are not influenced by storage of plasma at HO "C for as long as 4 mo (PC1 !I Hollman, unpublished observations, 1995).
Red wine has been reported to increase the antioxidative capacity of plasma ( 14, 40) . This effect was also ascribed to red wine flavonoids. Because of the close interaction between the hydrophilic and lipophilic antioxidant mechanisms, an increase in the antioxidant capacity of plasma could decrease LDL oxidizability in vivo and probably also in vitro. Fuhrman et al (14) assessed total plasma lipid peroxidation in vitro by mea suring TBARS after the addition of the free radical generator AAPH whereas we estimated potential plasma lipid peroxida tion by measuring a spectrum of relevant protective antioxi dants. It has been reported that urate, ascorbic acid, thiol proteins, u'-tocopherol, and bilirubin are the main contributors to total plasma antioxidant capacity (41 ). Our data showed that red or white wine did not influence the concentration of either lipophilic or hydrophilic antioxidanls; it is there I ore not sur prising that LDL, oxidizability was also not influenced.
A recent study by Ruf eL al (42) in rats reported that oral administration of low-alcohol red wine resulted in decreased alcohol-induced lipid peroxidation in plasma and reduced platelet aggregation in vivo. Ruf et al (42) suggested that alcohol promotes absorption of polyphenol ics in the intestine. Hitherto, few data were available on the absorption and me tabolism of individual flavonoids after consumption. Our knowledge of the absorption of flavonoids from foods is lim ited and studies of this kind are needed. The amounts absorbed may be insufficiënt to exert antioxidative activity in vitro either in tolal plasma or in isolated LDL.
In conclusion, consumption of a fairly large dose of red wine did not affect in vitro LDL oxidizability in volunteers, The French paradox, if it exists at ail, may be due to factors other than the effect of wine on LD L oxidation. 0
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